List of Tables
Table 1. Global Diabetic Foot Ulcer (DFU) Therapeutic Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Companies of Wound Care Dressing
Table 3. Major Companies of Biologics
Table 4. Major Companies of Therapy Devices
Table 5. Major Companies of Antibiotic Medications
Table 6. Major Companies of Others
Table 7. Global Diabetic Foot Ulcer (DFU) Therapeutic Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Diabetic Foot Ulcer (DFU) Therapeutic Market Size by Region (US$ Million): 2022 VS 2028
Table 9. Global Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Diabetic Foot Ulcer (DFU) Therapeutic Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 11. Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Company (2017-2022) & (US$ Million)
Table 12. Diabetic Foot Ulcer (DFU) Therapeutic Revenue Share by Company (2017-2022)
Table 13. Ranking of Global Top Diabetic Foot Ulcer (DFU) Therapeutic Players by Revenue (US$ Million) in 2021
Table 14. Global Diabetic Foot Ulcer (DFU) Therapeutic Companies Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 15. Global Diabetic Foot Ulcer (DFU) Therapeutic by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Diabetic Foot Ulcer (DFU) Therapeutic as of 2021)
Table 16. Global Diabetic Foot Ulcer (DFU) Therapeutic Companies Headquarters
Table 17. Global Diabetic Foot Ulcer (DFU) Therapeutic Companies Product & Service
Table 18. Date of International Companies Enter into Diabetic Foot Ulcer (DFU) Therapeutic Market
Table 19. Global Diabetic Foot Ulcer (DFU) Therapeutic Mergers & Acquisitions, Expansion Plans
Table 20. 3M Corporation Information
Table 21. 3M Description and Business Overview
Table 22. 3M Diabetic Foot Ulcer (DFU) Therapeutic Revenue (US$ Million) and Gross Margin (2017-2022)
Table 23. 3M Diabetic Foot Ulcer (DFU) Therapeutic Product
Table 24. 3M Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Product in 2021
Table 25. 3M Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Application in 2021
Table 26. 3M Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Geographic Area in 2021
Table 27. 3M Recent Development
Table 28. Smith & Nephew Corporation Information
Table 29. Smith & Nephew Description and Business Overview
Table 30. Smith & Nephew Diabetic Foot Ulcer (DFU) Therapeutic Revenue (US$ Million) and Gross Margin (2017-2022)
Table 31. Smith & Nephew Diabetic Foot Ulcer (DFU) Therapeutic Product
Table 32. Smith & Nephew Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Product in 2021
Table 33. Smith & Nephew Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Application in 2021
Table 34. Smith & Nephew Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Geographic Area in 2021
Table 35. Smith & Nephew Recent Development
Table 36. Molnlycke Health Care Corporation Information
Table 37. Molnlycke Health Care Description and Business Overview
Table 38. Molnlycke Health Care Diabetic Foot Ulcer (DFU) Therapeutic Revenue (US$ Million) and Gross Margin (2017-2022)
Table 39. Molnlycke Health Care Diabetic Foot Ulcer (DFU) Therapeutic Product
Table 40. Molnlycke Health Care Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Product in 2021
Table 41. Molnlycke Health Care Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Application in 2021
Table 42. Molnlycke Health Care Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Geographic Area in 2021
Table 43. Molnlycke Health Care Recent Development
Table 44. ConvaTec Corporation Information
Table 45. ConvaTec Description and Business Overview
Table 46. ConvaTec Diabetic Foot Ulcer (DFU) Therapeutic Revenue (US$ Million) and Gross Margin (2017-2022)
Table 47. ConvaTec Diabetic Foot Ulcer (DFU) Therapeutic Product
Table 48. ConvaTec Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Product in 2021
Table 49. ConvaTec Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Application in 2021
Table 50. ConvaTec Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Geographic Area in 2021
Table 51. ConvaTec Recent Development
Table 52. Coloplast Corporation Information
Table 53. Coloplast Description and Business Overview
Table 54. Coloplast Diabetic Foot Ulcer (DFU) Therapeutic Revenue (US$ Million) and Gross Margin (2017-2022)
Table 55. Coloplast Diabetic Foot Ulcer (DFU) Therapeutic Product
Table 56. Coloplast Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Product in 2021
Table 57. Coloplast Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Application in 2021
Table 58. Coloplast Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Geographic Area in 2021
Table 59. Coloplast Recent Development
Table 60. Integra LifeSciences Corporation Information
Table 61. Integra LifeSciences Description and Business Overview
Table 62. Integra LifeSciences Diabetic Foot Ulcer (DFU) Therapeutic Revenue (US$ Million) and Gross Margin (2017-2022)
Table 63. Integra LifeSciences Diabetic Foot Ulcer (DFU) Therapeutic Product
Table 64. Integra LifeSciences Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Product in 2021
Table 65. Integra LifeSciences Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Application in 2021
Table 66. Integra LifeSciences Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Geographic Area in 2021
Table 67. Essity (BSN Medical) Corporation Information
Table 68. Essity (BSN Medical) Description and Business Overview
Table 69. Essity (BSN Medical) Diabetic Foot Ulcer (DFU) Therapeutic Revenue (US$ Million) and Gross Margin (2017-2022)
Table 70. Essity (BSN Medical) Diabetic Foot Ulcer (DFU) Therapeutic Product
Table 71. Essity (BSN Medical) Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Product in 2021
Table 72. Essity (BSN Medical) Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Application in 2021
Table 73. Essity (BSN Medical) Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Geographic Area in 2021
Table 74. Medline Corporation Information
Table 75. Medline Description and Business Overview
Table 76. Medline Diabetic Foot Ulcer (DFU) Therapeutic Revenue (US$ Million) and Gross Margin (2017-2022)
Table 77. Medline Diabetic Foot Ulcer (DFU) Therapeutic Product
Table 78. Medline Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Product in 2021
Table 79. Medline Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Application in 2021
Table 80. Medline Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Geographic Area in 2021
Table 81. B. Braun Corporation Information
Table 82. B. Braun Description and Business Overview
Table 83. B. Braun Diabetic Foot Ulcer (DFU) Therapeutic Revenue (US$ Million) and Gross Margin (2017-2022)
Table 84. B. Braun Diabetic Foot Ulcer (DFU) Therapeutic Product
Table 85. B. Braun Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Product in 2021
Table 86. B. Braun Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Application in 2021
Table 87. B. Braun Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Geographic Area in 2021
Table 88. Organogenesis Corporation Information
Table 89. Organogenesis Description and Business Overview
Table 90. Organogenesis Diabetic Foot Ulcer (DFU) Therapeutic Revenue (US$ Million) and Gross Margin (2017-2022)
Table 91. Organogenesis Diabetic Foot Ulcer (DFU) Therapeutic Product
Table 92. Organogenesis Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Product in 2021
Table 93. Organogenesis Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Application in 2021
Table 94. Organogenesis Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Geographic Area in 2021
Table 95. Global Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Type (2017-2022) & (US$ Million)
Table 96. Global Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Application (2017-2022) & (US$ Million)
Table 97. Global Diabetic Foot Ulcer (DFU) Therapeutic Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 98. North America Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Country (2017-2022) & (US$ Million)
Table 99. North America Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Country (2023-2028) & (US$ Million)
Table 100. North America Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Type (2017-2022) & (US$ Million)
Table 101. North America Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Application (2017-2022) & (US$ Million)
Table 102. Asia-Pacific Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Region (2017-2028) & (US$ Million)
Table 103. Asia-Pacific Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Region (2023-2028) & (US$ Million)
Table 104. Asia-Pacific Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Type (2017-2022) & (US$ Million)
Table 105. Asia-Pacific Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Application (2017-2022) & (US$ Million)
Table 106. Europe Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Country (2017-2022) & (US$ Million)
Table 107. Europe Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Country (2023-2028) & (US$ Million)
Table 108. Europe Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Type (2017-2022) & (US$ Million)
Table 109. Europe Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Application (2017-2022) & (US$ Million)
Table 110. Latin America Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Country (2017-2022) & (US$ Million)
Table 111. Latin America Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Country (2023-2028) & (US$ Million)
Table 112. Latin America Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Type (2017-2022) & (US$ Million)
Table 113. Latin America Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Application (2017-2022) & (US$ Million)
Table 114. Middle East and Africa Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Country (2017-2022) & (US$ Million)
Table 115. Middle East and Africa Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Country (2023-2028) & (US$ Million)
Table 116. Middle East and Africa Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Type (2017-2022) & (US$ Million)
Table 117. Middle East and Africa Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Application (2017-2022) & (US$ Million)
Table 118. Diabetic Foot Ulcer (DFU) Therapeutic Key Raw Materials, Industry Status and Trend
Table 119. Diabetic Foot Ulcer (DFU) Therapeutic Key Raw Materials and Upstream Suppliers
Table 120. Diabetic Foot Ulcer (DFU) Therapeutic Clients Status and Trend
Table 121. Diabetic Foot Ulcer (DFU) Therapeutic Typical Clients
Table 122. Diabetic Foot Ulcer (DFU) Therapeutic Distributors
Table 123. Diabetic Foot Ulcer (DFU) Therapeutic Market Trends
Table 124. Diabetic Foot Ulcer (DFU) Therapeutic Market Drivers
Table 125. Diabetic Foot Ulcer (DFU) Therapeutic Market Challenges
Table 126. Diabetic Foot Ulcer (DFU) Therapeutic Market Restraints
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Diabetic Foot Ulcer (DFU) Therapeutic Product Picture
Figure 2. Global Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share by Type in 2021 & 2028
Figure 3. Wound Care Dressing Product Picture
Figure 4. Biologics Product Picture
Figure 5. Therapy Devices Product Picture
Figure 6. Antibiotic Medications Product Picture
Figure 7. Others Product Picture
Figure 8. Global Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share by Application in 2021 & 2028
Figure 9. Neuropathic Ulcers
Figure 10. Ischemic Ulcers
Figure 11. Neuro-ischemic Ulcers
Figure 12. Diabetic Foot Ulcer (DFU) Therapeutic Report Years Considered
Figure 13. Global Diabetic Foot Ulcer (DFU) Therapeutic Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Diabetic Foot Ulcer (DFU) Therapeutic Market Size 2017-2028 (US$ Million)
Figure 15. Global Diabetic Foot Ulcer (DFU) Therapeutic Market Size Market Share by Region: 2022 Versus 2028
Figure 16. Global Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share by Region (2017-2028)
Figure 17. Diabetic Foot Ulcer (DFU) Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share Forecast by Type (2017-2028)
Figure 19. Global Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share Forecast by Application (2017-2028)
Figure 20. North America Diabetic Foot Ulcer (DFU) Therapeutic Revenue 2017-2028 (US$ Million)
Figure 21. North America Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share by Type (2017-2022)
Figure 22. North America Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share by Application (2017-2022)
Figure 23. Asia-Pacific Diabetic Foot Ulcer (DFU) Therapeutic Revenue 2017-2028 (US$ Million)
Figure 24. Asia-Pacific Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share by Region (2017-2028)
Figure 25. Asia-Pacific Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share by Type (2017-2022)
Figure 26. Asia-Pacific Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share by Application (2017-2022)
Figure 27. Europe Diabetic Foot Ulcer (DFU) Therapeutic Revenue Growth Rate 2017-2028 (US$ Million)
Figure 28. Europe Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share by Country (2017-2028)
Figure 29. Europe Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share by Type (2017-2022)
Figure 30. Europe Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share by Application (2017-2022)
Figure 31. Latin America Diabetic Foot Ulcer (DFU) Therapeutic Revenue Growth Rate 2017-2028 (US$ Million)
Figure 32. Latin America Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share by Country (2017-2022)
Figure 33. Latin America Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share by Type (2017-2022)
Figure 34. Latin America Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share by Application (2017-2022)
Figure 35. Middle East and Africa Diabetic Foot Ulcer (DFU) Therapeutic Revenue Growth Rate 2017-2028 (US$ Million)
Figure 36. Middle East and Africa Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share by Country (2017-2028)
Figure 37. Middle East and Africa Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share by Type (2017-2022)
Figure 38. Middle East and Africa Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share by Application (2017-2022)
Figure 39. Diabetic Foot Ulcer (DFU) Therapeutic Supply Chain (Upstream and Downstream Market)
Figure 40. Global Production Market Share of Diabetic Foot Ulcer (DFU) Therapeutic Raw Materials by Region in 2021
Figure 41. Diabetic Foot Ulcer (DFU) Therapeutic Distribution Channels
Figure 42. Global Diabetic Foot Ulcer (DFU) Therapeutic Percentage 2017-2028: Indirect Sales VS Direct Sales
Figure 43. Global Diabetic Foot Ulcer (DFU) Therapeutic Percentage 2017-2028: Online Sales VS Offline Sales
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed